FUQA:LSE:LSE-Fidelity US Quality Income ETF Acc (GBX)

ETF | Others |

Last Closing

USD 905.375

Change

-10.88 (-1.19)%

Market Cap

USD 0.31B

Volume

1.97K

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-04-16 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
0R15:LSE SoftBank Group Corp.

N/A

USD 9,217.80B
0R1E:LSE Nintendo Co. Ltd.

N/A

USD 7,596.04B
0R1O:LSE Amazon.com Inc.

+1.75 (+0.98%)

USD 1,607.29B
0R1I:LSE NVIDIA Corp.

+8.60 (+0.99%)

USD 618.20B
LCJD:LSE Amundi MSCI Japan (DR) UCITS E..

+0.16 (+0.92%)

USD 617.54B
LCJP:LSE Lyxor Core MSCI Japan (DR) UCI..

+0.02 (+0.17%)

USD 617.54B
0R1G:LSE Home Depot Inc.

N/A

USD 373.16B
XDJP:LSE Xtrackers Nikkei 225 UCITS ETF..

+4.75 (+0.24%)

USD 348.03B
0QZK:LSE Coca-Cola Co.

-0.80 (-1.30%)

USD 266.08B
0QZO:LSE 0QZO

+0.70 (+0.62%)

USD 258.54B

ETFs Containing FUQA:LSE

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 5.81% 77% C+ 73% C
Dividend Return N/A N/A N/A N/A N/A
Total Return 5.81% 77% C+ 72% C
Trailing 12 Months  
Capital Gain 15.76% 73% C 74% C
Dividend Return N/A N/A N/A N/A N/A
Total Return 15.76% 73% C 74% C
Trailing 5 Years  
Capital Gain 83.55% 93% A 90% A-
Dividend Return N/A N/A N/A N/A N/A
Total Return 83.55% 91% A- 88% B+
Average Annual (5 Year Horizon)  
Capital Gain 12.10% 78% C+ 78% C+
Dividend Return 12.10% 78% C+ 77% C+
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 9.34% 71% C- 82% B
Risk Adjusted Return 129.58% 100% F 100% F
Market Capitalization 0.31B 63% D 54% F

Annual Financials (GBX)

Quarterly Financials (GBX)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior risk adjusted returns

This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.

What to not like:

There is nothing we particularly dislike